Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-013149

Bellerophon Therapeutics, Inc. · BLPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Adam Weinstein
Director · 10% Owner
Period of report
Feb 12, 2015
Accepted (ET)
Feb 23, 2015 · 9:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4Feb 12, 2015D460,144—D3,329,575ISee footnotes
Common StockF1,F5,F6Feb 12, 2015A460,144—A3,789,719ISee footnotes
Common StockF7,F8Feb 19, 2015P1,070,166$12.00A4,859,885ISee footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses